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Abstract 
Each year, according to parkinson.org, approximately 60,000 people in the US are 
diagnosed with Parkinson’s Disease (PD). PD is a neurodegenerative disorder that affects 
dopamine-producing neurons in the portion of the brain called the Substantia Nigra. Symptoms 
of PD include resting tremors, muscle rigidity, and speech difficulties regarding articulation and 
vocal quality. There is no cure for PD, however, pharmaceutical, behavioral, and surgical 
interventions such as deep brain stimulation (DBS) can be used to treat symptoms of PD. 
Although there is a significant amount of research regarding the effects of DBS in patients with 
PD, there is little evidence describing how DBS specifically affects speech and swallowing for 
individual patients with PD. This project is intended to analyze the impact of DBS on speech and 
swallowing in two patients with PD at follow up evaluations post-DBS implementation. 
Background: Key Terms/Definitions 
DBS: A surgical intervention involving the implantation of electrodes in the brain, and an 
impulse generator battery beneath the collarbone or abdomen. 
Formants: Amplified harmonics. Concentrations of acoustic energy  
Speech Intelligibility: How well a person's speech is understood by others. 
DDK: Measurement of how quickly someone can rapidly produce alternating sounds. 
Clinical Significance: Impact on clinical practice. 
HINT: Hearing in noise test. 
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Methods 
This project uses previously collected data from two participants (DBS 01 and DBS 02) 
who underwent DBS implantation. The original data were obtained pre-DBS implantation, post-
surgery, and at 3-month intervals following the post-surgical evaluation. The independent 
variables include:  (1) First and second formants of the vowels /a/, /i/, and /u/ during sentence 
reading to determine vowel space area. (2) Vocal intensity during paragraph reading from the 
"Farm passage." (3) Vocal intensity during picture description. The participants were given a 
picture and asked to describe the picture in detail for one-minute. (4) Percent speech 
intelligibility during a word reading task. Participants read words and sentences randomly 
selected from the Speech Intelligibility Test, and five listeners transcribed what they heard from 
audio recordings of this task. (5) Vocal intensity during a monologue. Participants discussed a 
topic of interest for one minute. (6) Perceptual data from questionnaires addressing 
communication and swallowing function. Participants completed self-assessments (EAT-10, 
VAS) rating quality of life related to speech, swallowing, eating, and socializing. (7) Oral motor 
examination to assess facial symmetry, lip, jaw, and tongue movement, dentition, hard palate 
integrity, soft palate elevation/symmetry, ability to follow motor commands, volitional cough, 
dry swallow, diadochokinetic rates (DDK) and word/sentence repetition. (8) Vocal intensity and 
duration of vowel prolongation. Participants sustained the vowel "ah" six times for as long as 
possible. (9) Rate and volume of swallowing during a timed swallow test, where participants 
drank 150ml of water as quickly as possible, swallowed three presentations of liquid (pureed 
applesauce), and ate several small cookies. (10) kPa of pressure generated by the tongue and lips 
was measured using the Iowa Oral Performance Instrument model (IOPI). The IOPI used a 
pressure transducer to determine right, left, and center lip pressures, as well as pressure between 
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the alveolar ridge and anterior tongue. (11) Pressure generated during maximum inspiration 
pressure (MIP) and maximum expiration pressure (MEP). These were measured using an 
RPM01 respiratory pressure meter. A mouthpiece was placed between the lips and tongue and 
secured with a bite block to measure MIP and MEP. 
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DBS 01 Results 
DBS 01 had statistically significant improvements from pre-post for the monologue on 
various topics (p value .011) and sustained “ah” phonation (p value .001). DBS 01 from pre-FU 
only had statistically significant improvements for the monologue (t value .039). DBS 01 effect 
size pre-post was small for sentence reading (.21), picture description (.34), monologue on 
various topics (.42), and sustained “ah” phonation (.23). DBS 01 effect size from pre-FU 
decreased for all tasks except for HINT sentences, where there was an increase from trivial to 
small effect size (increase from .18 to .21). All other effect sizes decreased from pre-FU, with 
small effect sizes remaining for picture description (.25), and monologue on various topics (.25). 
Overall, DBS 01's baseline loudness for all tasks was significantly below average for his age and 
gender. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Impact of Deep Brain Stimulation on Speech and Swallowing in Patients with 
Parksinson's Disease 
6 
DBS 02 Results 
DBS 02 had statistically significant improvements from pre-post for sentence reading (t 
value .020), word list reading (p value .042), monologue on various topics (t value.001) and 
sustained “ah” phonation (t value 0.00). DBS 02 pre-post effect size was small for paragraph 
reading (.28), word list reading (.26) and monologue on various topics (.38). DBS 02 pre-post 
effect size was moderate for sentence reading (.51), and large for sustained "ah" phonation. DBS 
02 pre-post effect size was trivial for picture description (.05) and HINT sentences (.04). DBS 02 
pre-FU effect size was large for sustained “ah” phonation (.82), moderate for sentence reading 
(.51), and small for paragraph reading (.28), word list reading (.26) and monologue on various 
topics (.38). DBS 02 had statistically significant improvement pre-FU for all tasks, and each task 
had a large effect size except for word list reading (.47).  
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Discussion 
T-tests and effect sizes were calculated for each patient from pre-post, and from post-FU 
to determine statistical and clinical significance. Overall, DBS 01's baseline loudness for all tasks 
was significantly below average for his age and gender. DBS 01 showed statistically significant 
improvements from pre-post for monologue on various topics and sustained "ah" phonation, but 
from pre-FU, there were only statistically significant improvements for the monologue. DBS 01 
showed clinical significance for picture description and monologue on various topics from pre-
post, as these tasks had a small effect size. DBS 01 also showed clinical significance from pre-
FU for HINT sentences, where the effect size increased from trivial to small, despite effect sizes 
decreasing for all other tasks. DBS 02 showed statistically and clinically significant 
improvement for all tasks. DBS 02's p-values from pre-FU were 0.00 for all speech tasks. DBS 
02 had effect sizes from pre-post ranging from trivial to moderate. DBS 02's effect sizes from 
pre-FU increased to be large for all speech tasks except word list reading, as the effect size grew 
from small to moderate. These data show that DBS 02 had statistically and clinically significant 
improvements following DBS implementation for all speech tasks.  
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